Insider Trading Alert - LKFN, ATHN And OLN Traded By Insiders

Stocks with insider trader activity include LKFN, ATHN and OLN
By TheStreet Wire ,

Friday, Nov. 6, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $473.82 to $10,527,076.00.

Highlighted Stocks Traded by Insiders:

Lakeland Financial (LKFN) - FREE Research Report

De Batty Jill A, who is Senior Vice President at Lakeland Financial, sold 500 shares at $47.20 on Nov. 6, 2015. Following this transaction, the Senior Vice President owned 1,742 shares meaning that the stake was reduced by 22.3% with the 500-share transaction.

The shares most recently traded at $48.03, up $0.83, or 1.73% since the insider transaction. Historical insider transactions for Lakeland Financial go as follows:

  • 4-Week # shares bought: 123
  • 4-Week # shares sold: 600
  • 12-Week # shares bought: 623
  • 12-Week # shares sold: 600
  • 24-Week # shares bought: 1,762
  • 24-Week # shares sold: 838

The average volume for Lakeland Financial has been 55,000 shares per day over the past 30 days. Lakeland Financial has a market cap of $778.8 million and is part of the financial sector and banking industry. Shares are up 10.7% year-to-date as of the close of trading on Friday.

Lakeland Financial Corporation operates as the holding company for Lake City Bank that provides various financial services to individuals and businesses in Indiana, the United States. The stock currently has a dividend yield of 2.09%. The company has a P/E ratio of 17.4. Currently, there is 1 analyst who rates Lakeland Financial a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LKFN - FREE

TheStreet Quant Ratings

rates Lakeland Financial as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in net income and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Lakeland Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AthenaHealth (ATHN) - FREE Research Report

Park Ed, who is EVP and COO at AthenaHealth, sold 1,500 shares at $162.32 on Nov. 6, 2015. Following this transaction, the EVP and COO owned 31,933 shares meaning that the stake was reduced by 4.49% with the 1,500-share transaction.

The shares most recently traded at $163.93, up $1.61, or 0.98% since the insider transaction. Historical insider transactions for AthenaHealth go as follows:

  • 4-Week # shares sold: 8,415
  • 12-Week # shares sold: 17,174
  • 24-Week # shares sold: 20,674

The average volume for AthenaHealth has been 467,600 shares per day over the past 30 days. AthenaHealth has a market cap of $6.3 billion and is part of the technology sector and computer software & services industry. Shares are up 12.35% year-to-date as of the close of trading on Friday.

athenahealth, Inc., together with its subsidiaries, operates as a business services company that provides ongoing billing, clinical-related, and other related services to medical group practices and health systems in the United States. The company has a P/E ratio of 412.9. Currently, there are 11 analysts who rate AthenaHealth a buy, 2 analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATHN - FREE

TheStreet Quant Ratings

rates AthenaHealth as a

hold

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, robust revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including premium valuation and weak operating cash flow. Get the full

AthenaHealth Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Olin (OLN) - FREE Research Report

Rompala Richard M, who is Director at Olin, bought 50,000 shares at $19.51 on Nov. 6, 2015. Following this transaction, the Director owned 50,500 shares meaning that the stake was boosted by 10000% with the 50,000-share transaction.

Schulz Philip J, who is Director at Olin, bought 21,100 shares at $20.08 on Nov. 6, 2015. Following this transaction, the Director owned 42,801 shares meaning that the stake was boosted by 97.23% with the 21,100-share transaction.

Smith Vince J, who is Director at Olin, bought 10,000 shares at $19.90 on Nov. 6, 2015. Following this transaction, the Director owned 25,639 shares meaning that the stake was boosted by 63.94% with the 10,000-share transaction.

The shares most recently traded at $20.23, up $0.33, or 1.63% since the insider transaction. Historical insider transactions for Olin go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 4,772
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 4,772
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 4,772

The average volume for Olin has been 4.0 million shares per day over the past 30 days. Olin has a market cap of $1.5 billion and is part of the basic materials sector and chemicals industry. Shares are down 10.58% year-to-date as of the close of trading on Friday.

Olin Corporation manufactures and sells chlor alkali products in the United States and internationally. The company operates through three segments: Chlor Alkali Products, Chemical Distribution, and Winchester. The stock currently has a dividend yield of 4.12%. The company has a P/E ratio of 20.4. Currently, there are 4 analysts who rate Olin a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OLN - FREE

TheStreet Quant Ratings

rates Olin as a

hold

. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full

Olin Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...